Qin M. Wen
Xinqiao Street
Xinqiao, 400037, China
Xinqiao, 400037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Erratum: [Corrigendum] Inhibition of microRNA-221-5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cells.
Journal: Oncology letters
Published: April 01, 2026
Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia.
Journal: Blood science (Baltimore, Md.)
Published: January 27, 2026
Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 07, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
MMRN1-EGFR drives sialylglycan-Siglec immune evasion in AML leukemia stem cells.
Journal: Cell stem cell
Published: June 23, 2025
Refractory splenic tuberculosis in acute myeloid Leukemia: The role of advanced diagnostics and surgical intervention.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: June 05, 2025
Mechanisms of Clostridioides difficile glucosyltransferase toxins and their roles in pathology: insights and emerging therapeutic strategies.
Journal: Frontiers in cellular and infection microbiology
Published: June 05, 2025
Targeting SIRT6 epigenetically restrains neutrophil hyperplasia and enhances chemotherapeutic efficacy.
Journal: Acta pharmaceutica Sinica. B
Published: June 04, 2025
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.
Journal: Haematologica
Published: May 15, 2025
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 15, 2025
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia.
Journal: Haematologica
Published: December 04, 2024
Last Updated: 09/26/2026